Targeting p38γ synergistically enhances sorafenib-induced cytotoxicity in hepatocellular carcinoma

被引:0
|
作者
Chen Huang [1 ]
Chenliang Zhang [2 ]
Jiajin Li [1 ]
Yichun Duan [2 ]
Qiulin Tang [3 ]
Feng Bi [2 ]
机构
[1] West China Hospital,Division of Abdominal Tumor Multimodality Treatment, Cancer Center and Laboratory of Molecular Targeted Therapy in Oncology
[2] Sichuan University,Division of Abdominal Tumor Multimodality Treatment
[3] West China Hospital,undefined
[4] Sichuan University,undefined
[5] Sichuan University,undefined
[6] West China Hospital of Sichuan University,undefined
关键词
Hepatocellular carcinoma; Sorafenib; P38γ; Autophagy; Cell drug resistance;
D O I
10.1007/s10565-024-09979-x
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Sorafenib-induced acute interstitial pneumonia in patients with advanced hepatocellular carcinoma: Report of three cases
    Takeda H.
    Nishikawa H.
    Iguchi E.
    Matsuda F.
    Kita R.
    Kimura T.
    Osaki Y.
    Clinical Journal of Gastroenterology, 2012, 5 (6) : 407 - 412
  • [32] p38β promotes cancer stemness and chemoresistance in hepatocellular carcinoma
    Huang, Ianto Bosheng
    Xie, Yunong
    Wong, Tin Lok
    Lee, Terence Kin Wah
    Yun, Jing-Ping
    Ma, Stephanie Kwai Yee
    Tong, Man
    CANCER RESEARCH, 2023, 83 (07)
  • [33] Target identification by phosphoproteomics: RIN1 modulation of sorafenib-induced cytotoxicity in renal cell carcinoma
    Grozav, A. G.
    Willard, B.
    Kinter, M.
    Vaziri, S. A.
    Bukowski, R. M.
    Rini, B. I.
    Ganapathi, M. K.
    Ganapathi, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [34] Diagnostic Significance of p38 Isoforms (p38α, p38β, p38γ, p38δ) in Head and Neck Squamous Cell Carcinoma: Comparative Serum Level Evaluation and Design of Novel Peptide Inhibitor Targeting the Same
    Sahu, Vishal
    Nigam, Lokesh
    Agnihotri, Vertica
    Gupta, Abhishek
    Shekhar, Shashank
    Subbarao, Naidu
    Bhaskar, Suntan
    Dey, Sharmistha
    CANCER RESEARCH AND TREATMENT, 2019, 51 (01): : 313 - 325
  • [35] AKR1B10 Inhibitor Epalrestat Facilitates Sorafenib-Induced Apoptosis and Autophagy Via Targeting the mTOR Pathway in Hepatocellular Carcinoma
    Geng, Nan
    Jin, Yuanyuan
    Li, Yurong
    Zhu, Shixuan
    Bai, Han
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2020, 17 (09): : 1246 - 1256
  • [36] Targeting adenosinergic pathway enhances the anti-tumor efficacy of sorafenib in hepatocellular carcinoma
    Jing Liao
    Dan-Ni Zeng
    Jin-Zhu Li
    Qiao-Min Hua
    Zhiyu Xiao
    Chuanchao He
    Kai Mao
    Ling-Yan Zhu
    Yifan Chu
    Wei-Ping Wen
    Limin Zheng
    Yan Wu
    Hepatology International, 2020, 14 : 80 - 95
  • [37] Targeting adenosinergic pathway enhances the anti-tumor efficacy of sorafenib in hepatocellular carcinoma
    Liao, Jing
    Zeng, Dan-Ni
    Li, Jin-Zhu
    Hua, Qiao-Min
    Xiao, Zhiyu
    He, Chuanchao
    Mao, Kai
    Zhu, Ling-Yan
    Chu, Yifan
    Wen, Wei-Ping
    Zheng, Limin
    Wu, Yan
    HEPATOLOGY INTERNATIONAL, 2020, 14 (01) : 80 - 95
  • [38] SLC27A5 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by downregulating glutathione reductase
    Xu, Feng-li
    Wu, Xiao-hong
    Chen, Chang
    Wang, Kai
    Huang, Lu-yi
    Xia, Jie
    Liu, Yi
    Shan, Xue-feng
    Tang, Ni
    CELL DEATH & DISEASE, 2023, 14 (01)
  • [39] Indole-3- carbinol enhances sorafenib cytotoxicity in hepatocellular carcinoma cells: A mechanistic study
    Mai M. Abdelmageed
    Reem N. El-Naga
    Ebtehal El-Demerdash
    Mohamed M. Elmazar
    Scientific Reports, 6
  • [40] Indole-3-carbinol enhances sorafenib cytotoxicity in hepatocellular carcinoma cells: A mechanistic study
    Abdelmageed, Mai M.
    El-Naga, Reem N.
    El-Demerdash, Ebtehal
    Elmazar, Mohamed M.
    SCIENTIFIC REPORTS, 2016, 6